| |
| |
|
| Insider
Information: |
Gould Robert J |
| Relationship: |
Interim President & CE... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
499,864 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
499,864 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Epizyme, Inc. |
EPZM |
Director |
2015-12-30 |
0 |
2014-01-02 |
0 |
Premium* |
|
|
Fulcrum Therapeutics, Inc. |
FULC |
Interim President & CE... |
2023-01-13 |
499,864 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-04 |
4 |
AS |
$24.02 |
$173,749 |
D/D |
(7,235) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-05 |
4 |
OE |
$7.84 |
$412,008 |
D/D |
52,552 |
559,182 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-05 |
4 |
AS |
$24.26 |
$1,274,775 |
D/D |
(52,552) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-07 |
4 |
OE |
$7.84 |
$44,147 |
D/D |
5,631 |
512,261 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-04-07 |
4 |
AS |
$24.02 |
$135,228 |
D/D |
(5,631) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-02 |
4 |
AS |
$7.92 |
$132,162 |
D/D |
(16,689) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-02 |
4 |
OE |
$7.84 |
$130,842 |
D/D |
16,689 |
523,319 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-03 |
4 |
OE |
$7.84 |
$200,320 |
D/D |
25,551 |
532,181 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-03 |
4 |
AS |
$7.95 |
$203,056 |
D/D |
(25,551) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-06 |
4 |
OE |
$7.84 |
$191,155 |
D/D |
24,382 |
531,012 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-06 |
4 |
AS |
$8.10 |
$197,592 |
D/D |
(24,382) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-07 |
4 |
OE |
$7.84 |
$560,050 |
D/D |
71,435 |
578,065 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Director |
– • – |
2022-06-07 |
4 |
AS |
$8.09 |
$577,895 |
D/D |
(71,435) |
506,630 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Interim President & CEO |
• • – |
2023-01-13 |
4 |
AS |
$15.00 |
$101,490 |
D/D |
(6,766) |
499,864 |
0 |
- |
|
64 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
